Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
Clinical trial NCT06209606 · RECRUITING
Trial details
- NCT number
- NCT06209606
- Sponsor
- Oncotherapeutics
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2026-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.